Healthcare
Monday, December 19, 2016
Israel's BrainStorm to begin advanced trial for ALS stem cell treatment
TEL AVIV, Dec 19 (Reuters) - Israel's BrainStorm Cell
Therapeutics said it is proceeding to a Phase 3
clinical trial for its adult stem cell treatment in patients
with amyotrophic lateral sclerosis (ALS).
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment